- Filed
- Jul 10, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2025 · Jul 7, 2025 | 11.08M sh |
| Shares Diluted | FY 2025 · Mar 31, 2025 | 10.52M sh |
| Shares Diluted | FY 2025 · Mar 31, 2024 | 8.86M sh |
| Capex | FY 2025 · Mar 31, 2025 | $1.6K |
| Capex | FY 2025 · Mar 31, 2024 | $671.68K |
| Operating Cash Flow | FY 2025 · Mar 31, 2025 | $500.3K |
| Operating Cash Flow | FY 2025 · Mar 31, 2024 | $7.24K |
| Cash And Equivalents | FY 2025 · Mar 31, 2025 | $833.58K |
| Cash And Equivalents restated | FY 2025 · Mar 31, 2024 | $737.72K |
| Stockholders Equity | FY 2025 · Mar 31, 2025 | −$2.86M |
| Stockholders Equity | FY 2025 · Mar 31, 2024 | $894.9K |
| Current Liabilities | FY 2025 · Mar 31, 2025 | $5.22M |
| Current Liabilities | FY 2025 · Mar 31, 2024 | $5.34M |
| Total Liabilities | FY 2025 · Mar 31, 2025 | $5.22M |
| Total Liabilities | FY 2025 · Mar 31, 2024 | $5.57M |
| Current Assets | FY 2025 · Mar 31, 2025 | $2.24M |
| Current Assets | FY 2025 · Mar 31, 2024 | $2.65M |
| Total Assets | FY 2025 · Mar 31, 2025 | $5.8M |
| Total Assets | FY 2025 · Mar 31, 2024 | $9.86M |
| Eps Diluted | FY 2025 · Mar 31, 2025 | −$0.35 |
| Eps Diluted | FY 2025 · Mar 31, 2024 | −$0.41 |
| Eps Basic | FY 2025 · Mar 31, 2025 | −$0.35 |
| Eps Basic | FY 2025 · Mar 31, 2024 | −$0.41 |
| Sga Expense | FY 2025 · Mar 31, 2025 | $2.62M |
| Sga Expense restated | FY 2025 · Mar 31, 2024 | $3.13M |
| Net Income | FY 2025 · Mar 31, 2025 | −$3.73M |
| Net Income | FY 2025 · Mar 31, 2024 | −$3.67M |
| Operating Income | FY 2025 · Mar 31, 2025 | −$3.87M |
| Operating Income restated | FY 2025 · Mar 31, 2024 | −$4.38M |
| Gross Profit | FY 2025 · Mar 31, 2025 | $849.8K |
| Gross Profit restated | FY 2025 · Mar 31, 2024 | $924.73K |
| Cost Of Revenue | FY 2025 · Mar 31, 2025 | $2.54M |
| Cost Of Revenue restated | FY 2025 · Mar 31, 2024 | $3.4M |
| Revenue | FY 2025 · Mar 31, 2025 | $3.34M |
| Revenue restated | FY 2025 · Mar 31, 2024 | $4.29M |